Last reviewed · How we verify

NCT05763498

Uterine Junctional Zone and Its Relation to Adverse Obstetrical Outcomes in Assisted Reproductive Technology

Recruiting now Last updated 20 August 2024
What this trial tests

trial in Infertility, Female in 200 participants. Currently enrolling.

Timeline
24 February 2023
Primary endpoint
28 February 2025
31 July 2025

Quick facts

Lead sponsorCentro Hospitalar Lisboa Norte
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date24 February 2023
Primary completion28 February 2025
Estimated completion31 July 2025
Sites3 locations across Portugal

Conditions studied

Sponsor

Centro Hospitalar Lisboa Norte

Who can join

Adults 18 to 40, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The junctional zone (JZ) is an internal layer of the myometrium, with unique characteristics that allow its visualization as a hypoechogenic structure in three-dimensional (3D) ultrasound. While there is a growing realization that the origins of major obstetrical complications associated with defective deep placentation, such as pre-term labour, fetal growth restriction and pre-eclampsia, may lie in the very early pregnancy events, the underlying mechanisms are not understood.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

Other Centro Hospitalar Lisboa Norte trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05763498.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing